# Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age

> **NCT05856227** · PHASE3 · COMPLETED · sponsor: **Basilea Pharmaceutica** · enrollment: 9 (actual)

## Conditions studied

- Neonatal Sepsis

## Interventions

- **DRUG:** Ceftobiprole medocaril

## Key facts

- **NCT ID:** NCT05856227
- **Lead sponsor:** Basilea Pharmaceutica
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-06
- **Primary completion:** 2024-12-18
- **Final completion:** 2024-12-18
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2025-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05856227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05856227, "Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05856227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*